Our results showed that Vδ2 T cells from SLE patients overexpressed CD40L and produced increased levels of IL-21, which were downregulated during remission after treatment, suggesting that Vδ2 T cells are important in promoting B cell hyperactivation in SLE. This evidence concerns the gene CD40LG and systemic lupus erythematosus.